Last updated 33 days ago

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

1000 patients around the world

Available in Puerto Rico, Spain, Brazil, United States

AbbVie

16Research sites

1000Patients around the world

This study is for people with

Lupus

Systemic lupus erythematosus

Requirements for the patient

To 63 Years

All Gender

Medical requirements

Sites

Organización Médica de Investigación (OMI)

Uruguay 725 PB , Buenos Aires, CP: 1015

Fundación Sanatorio Güemes - CABA, Buenos Aires

Fco Acuña de Figueroa 1228fsg.org.ar/investigacion.htm

CER Instituto Médico - Quilmes, Buenos Aires

Av. Vicente Lopez 1441, Quilmes, Buenos Aireshttps://www.institutocer.com.ar/en

Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich

Av. Luis Maria Campos 726, CABA, Buenos Aires

Instituto CAICI - Rosario, Santa Fe

Mendoza 2612, Rosario, Santa Fe

Centro de Investigaciones Médicas Tucumán

San Miguel de Tucuman, Tucuman, T4000AXL

Instituto Médico Especializado (IME)

Hidalgo 568, CABA, Buenos Aires

Fundación CIDEA - Buenos Aires

Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina

Aprillus Asistencia e Investigación

Terrada 89, Flores, CABA

Hospital Italiano de La Plata

Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires

Centro Mineiro de Pesquisa - CMIP

Recruiting

Rua Delfim Moreira, 186, Centro Juiz de Fora, Minas Gerais, CEP: 36010-570

Centro Internacional de Estudios Clínicos - CIEC

Recruiting

Calle Manzano 343, Oficina 410-411, Comuna de Recoleta, Región Metropolitana, 8420383

GCM Medical Group

Recruiting

San Juan, 00917

Clinical Research Puerto Rico

Recruiting

359 Avenida José de Diego Suite 501 00909-1711, San Juan, 00921

Mindful Medical Research

Recruiting

San Juan, 00918

Caribbean Medical Research Center

Recruiting

121 Calle Manuel Domenech, San Juan, 00918, Puerto Rico

StudySELECT-SLE

SponsorAbbVie

Conditions

Systemic lupus erythematosus

Requirements

To 63 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05843643